Physician Therapeutics Presents Data on Medical Food Theramine® at Scientific Conferences

Los Angeles, September 27, 2012 — Physician Therapeutics, a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, will present data examining the effectiveness of its medical food Theramine® and low dose ibuprofen for the management of chronic back pain at several upcoming scientific conferences.

The scientific poster titled, “Theramine versus ibuprofen for the safe and effective management of chronic low back pain and inflammation,” was first presented on September 6 at PAINWeek 2012, held in Las Vegas, Nevada. The data is scheduled to be presented at scientific conferences and meetings in the next six months, including the 118th Annual Meeting of AMSUS in Phoenix, Arizona on November 13, 2012.

“Incorporating medical foods into pain management regimens is gaining wide attention and we are delighted to present these data to a national audience of physicians, pharmacists and psychologists, as well as a broad array of disciplines within the medical community,” said David S. Silver M.D., corresponding author of the abstract, and executive VP of medical and scientific affairs at Targeted Medical Pharma, Inc.

The randomized, doubleblind placebocontrolled study of 130 patients sought to determine whether Theramine is an effective analgesic in the treatment of chronic back pain and if it could aid in reducing inflammatory markers. The full poster, including the study results, may be downloaded by visiting: (http://bit.ly/theraminevsibuprofen).

Full Citation:

Theramine versus Ibuprofen for the safe and effective management of chronic low back pain and inflammation.” William E. Shell M.D., David S. Silver M.D., Fred McCall-Perez Ph.D., Stephanie Pavlik C.R.A.

About Physician Therapeutics’ Medical Foods

Physician Therapeutics’ medical foods are amino acid based, FDA-regulated medications specially formulated to meet the body’s increased nutritional requirements of disease. They are a safe and effective option for treating pain syndromes, sleep and cognitive disorders, hypertension and obesity without harmful side effects. Physician Therapeutics’ medical foods are available by prescription only and must be administered under the ongoing supervision of a physician.

About Physician Therapeutics and Targeted Medical Pharma, Inc.

Physician Therapeutics is a division of Targeted Medical Pharma, Inc., a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of chronic disease including pain syndromes, obesity, sleep and cognitive disorders, and hypertension. Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are sold in the United States and Japan. The company manufactures nine proprietary medical foods, as well as 48 convenience pack kits, which pair a medical food and branded or generic pharmaceutical. These prescription medications and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.

####

Targeted Medical Pharma Reports Preliminary Data on Red Blood Cell Stimulating Formulation

Los Angeles, Sept. 17, 2012 — Targeted Medical Pharma, Inc. a specialty pharmaceutical company that develops and distributes prescription medical foods to physicians, pharmacies and skilled nursing facilities, today unveiled preliminary data indicating that its new amino acid oral formulation stimulated red blood cell and platelet development during an investigational study.

Initial results showed that the company’s new amino acid based formulation increased red blood cell counts, including reticulocytes, the precursors of red blood cells, as well as hemoglobin and hematocrit.  The study also found a 30 percent rise in circulating platelets after seven days, as well as a 16 percent increase in hemoglobin and a 450 percent increase in peripheral reticulocytes (p<0.01).

“We are thrilled that our new orally administered formulation increased the number of red blood cells in patients, emphasizing the need for the initiation of a further studies,” said William Shell, M.D., CEO of Targeted Medical Pharma, Inc. and lead scientist of the study. “What’s truly a benefit is that our formulation produces similar results as an approved injected medication.” 

The company noted that its new amino acid based formulation can potentially be used to manage anemia related to a variety of chronic diseases

Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a specialty pharmaceutical company that develops and sells prescription medical foods to physicians, pharmacies and skilled nursing facilities for the treatment of chronic disease including  pain syndromes, obesity, and sleep and cognitive disorders.  Based in Los Angeles, the company’s proprietary pharmaceutical therapeutic systems are sold in the United States and Japan. The company manufactures nine proprietary medical foods, as well as 48 convenience pack kits, which pair a medical food and branded or generic pharmaceutical.  These prescription medications and therapeutic systems represent a novel approach to the management of certain disease states, focusing on safety and efficacy without the deleterious side effects of traditional, high dose prescription drugs.